Concomitant sickle cell disease and systemic lupus erythematosus: A single-center case series

Ajibike Lapite1,2, Luisana M Sánchez3, Ana Luiza Altaffer2,4

  • 1Division of Hematology/Oncology, Texas Children's Hospital, Houston, Texas, USA.

PubMed

Insights

Sickle cell disease (SCD) and systemic lupus erythematosus (SLE) share overlapping symptoms, complicating diagnosis. This study reviews institutional experience managing these concurrent autoimmune and hematologic disorders for better recognition and treatment.

Area of Science:

  • Hematology and Immunology
  • Autoimmune Disorders
  • Complement Pathway Abnormalities

Background:

  • Sickle cell disease (SCD) involves complement pathway abnormalities, potentially increasing autoimmune risk.
  • Systemic lupus erythematosus (SLE) presents with multisystemic manifestations.
  • SLE symptoms can mimic SCD, delaying diagnosis and treatment in affected patients.

Purpose of the Study:

  • To describe the institutional experience in diagnosing and managing patients with concomitant SCD and SLE.
  • To elucidate the complex interplay between SCD and SLE.
  • To improve early recognition and effective management strategies for concurrent SCD and SLE.

Main Methods:

  • Retrospective review of institutional patient cases with co-occurring SCD and SLE.
  • Analysis of diagnostic challenges and therapeutic approaches.
  • Evaluation of clinical presentations and management outcomes.

Main Results:

  • Detailed case series of patients with concurrent SCD and SLE.
  • Identified diagnostic delays due to overlapping clinical features.
  • Outlined specific management strategies employed for dual diagnoses.

Conclusions:

  • Concurrent SCD and SLE present unique diagnostic and management challenges.
  • Understanding the interplay between these conditions is crucial for timely diagnosis.
  • Effective management requires tailored approaches considering both hematologic and autoimmune aspects.